𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A mucosal vaccination approach for herpes simplex virus type 2

✍ Scribed by Rebecca S. Tirabassi; Christopher I. Ace; Tatyana Levchenko; Vladimir P. Torchilin; Liisa K. Selin; Siwei Nie; Dennis L. Guberski; Kejian Yang

Book ID
116963303
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
352 KB
Volume
29
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Herpes simplex virus type 2 and cancer:
Herpes simplex virus type 2 and cancer: A medical geography approach
✍ FrΓ©dΓ©ric Thomas; Eric Elguero; Jacques Brodeur; Jerome Le Goff; DorothΓ©e MissΓ© πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 185 KB

Herpes simplex virus type-2 (HSV-2) has been identified as a possible aetiological agent of cancer in humans, especially prostate cancer, but results remain controversial. Here, we have addressed this question using a medical geography approach based on the national incidence of various cancers and

A nonlytic transforming mutant of herpes
A nonlytic transforming mutant of herpes simplex virus type 2
✍ Mary K. Howett; Fred Rapp πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 900 KB

## Abstract A small‐plaque mutant (No. 69) of herpes simplex virus type 2 (HSV‐2) strain 333 has been previously isolated and characterized in this laboratory. This mutant was shown to produce a high ratio of noninfectious to infectious particles when grown at the nonpermissive temperature in hamst